Pandy Song joined Northern Light in 2016. Prior to NLVC, Pandy worked in Department of Pharmacology and Department of Strategic Research in Staidson Biopharmaceutical Co., Ltd. He has a profound understanding for China's pharmaceutical industry. He has extensive experiences not only in corporate strategic planning and implementation, but also in clinical trial applications.

Pandy holds a PhD in Biophysics from Chinese Academy of Medical Sciences & Peking Union Medical College.